Comparative transcriptome analysis of human aorta atherosclerotic lesions and peripheral blood leukocytes from essential hypertension patients

Kardiologiya

Volumn 49, Issue 9, 2009, Pages 27-38

  Timofeeva, A V ^a   Goryunova, L E ^a   Khaspekov, G L ^a   Ilyinskaya, O P ^a   Sirotkin, V N ^a   Andreeva, E R ^a   Tararak, E M ^a   Bulkina, O S ^a   Buza, V V ^a   Britareva, V V ^a   Karpov, Yu A ^a   Beabealashvilli, R Sh ^a  

^a INSTITUTE OF EXPERIMENTAL CARDIOLOGY   (Russian Federation)

Author keywords

Atherosclerotic lesion types; Cdna microarray; Essential hypertension; Gene expression; Human aorta; Immunohistochemistry; RT PCR

Indexed keywords

BIOLOGICAL MARKER; COMPLEMENTARY DNA;

ABDOMINAL AORTA; ADULT; AGED; ARTICLE; ATHEROSCLEROSIS; FEMALE; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENETICS; HUMAN; HYPERTENSION; IMMUNOHISTOCHEMISTRY; LEUKOCYTE; MALE; METABOLISM; METHODOLOGY; MIDDLE AGED; PATHOLOGY; PROGNOSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ADULT; AGED; AGED, 80 AND OVER; AORTA, ABDOMINAL; ATHEROSCLEROSIS; BIOLOGICAL MARKERS; DNA, COMPLEMENTARY; FEMALE; GENE EXPRESSION; GENE EXPRESSION PROFILING; HUMANS; HYPERTENSION; IMMUNOHISTOCHEMISTRY; LEUKOCYTES; MALE; MIDDLE AGED; PROGNOSIS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; YOUNG ADULT;

EID: 74949133174     PISSN: 00229040     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Alexander R. W. Theodore Cooper Memorial Lecture. Hypertension and the pathogenesis of atherosclerosis. Oxidative stress and the mediation of arterial inflammatory response: a new perspective. Hypertension 1995;25:155-161.
2. Ross R. Atherosclerosis - an inflammatory disease. N Engl J Med 1999;340:115-126.
3. Glass C. K., Witztum J. L. Atherosclerosis: the road ahead. Cell 2001;104:503-516.
4. Lu H., Cassis L. A., Daugherty A. Atherosclerosis and arterial blood pressure in mice. Curr Drug Targets 2007;8:1181-1189.
5. Timofeeva A. V., Goryunova L. E., Khaspekov G. L. et al. Altered gene expression pattern in peripheral blood leukocytes from patients with arterial hypertension. Ann N Y Acad Sci 2006;1091:319-335.
6. Chon H., Gaillard C. A., van der Meijden B. B. et al. Broadly altered gene expression in blood leukocytes in essential hypertension is absent during treatment. Hypertension 2004;43:947-951.
7. Shiffman D., Mikita T., Tai J. T. et al. Large scale gene expression analysis of cholesterol-loaded macrophages. J Biol Chem 2000;275:37324-37332.
8. Li H., Lewis A., Brodsky S. et al. Homocysteine induces 3-hydroxy-3-methylglutaryl coenzyme a reductase in vascular endothelial cells: a mechanism for development of atherosclerosis? Circulation 2002;105:1037-1043.
9. Mikita T., Porter G., Lawn R. M., Shiffman D. Oxidized low density lipoprotein exposure alters the transcriptional response of macrophages to inflammatory stimulus. J Biol Chem 2001;276:5729-45739.
10. Ohura N., Yamamoto K., Ichioka S. et al. Global analysis of shear stress-responsive genes in vascular endothelial cells. J Atheroscler Thromb 2003;10:304-313.
11. King J. Y., Ferrara R., Tabibiazar R. et al. Pathway analysis of coronary atherosclerosis. Physiol Genomics 2005;23:103-118.
12. Seo D., Wang T., Dressman H. et al. Gene expression phenotypes of atherosclerosis. Arterioscler Thromb Vase Biol 2004;24:1922-1927.
13. Faber B. C., Cleutjens K. B., Niessen R. L. et al. Identification of genes potentially involved in rupture of human atherosclerotic plaques. Circ Res 2001;89:547-554.
14. Stary H. C., Chandler A. B., Dinsmore R. E. et al. A definition of advanced types of atherosclerotic lesions and a histological classification of atherosclerosis. A report from the Committee on Vascular Lesions of the Council on Arteriosclerosis, American Heart Association. Arterioscler Thromb Vase Biol 1995;15:1512-1531.
15. Eisen M. B., Spellman P. T., Brown P. O., Botstein D. Cluster analysis and display of genome-wide expression patterns. Proc Natl Acad Sci USA 1998;95:14863-14868.
16. Ashkar S., Weber G. F., Panoutsakopoulou V. et al. Eta-1 (osteopontin): an early component of type-1 (cell-mediated) immunity. Science 2000;287:860-864.
17. Wabnitz G. H., Kocher T., Lohneis P. et al. Costimulation induced phosphorylation of L plastin facilitates surface transport of the T cell activation molecules CD69 and CD25. Eur J Immunol 2007;37:649-662.
18. Boldt K., Rist W., Weiss S. M. et al. FPRL-1 induces modifications of migration-associated proteins in human neutrophils. Proteomics 2006;6:4790-4799.
19. Tarrant J. M., Robb L., van Spriel A. B., Wright M. D. Tetraspanins: molecular organisers of the leukocyte surface. Trends Immunol 2003;24:610-617.
20. Yunta M., Lazo P. A. Tetraspanin proteins as organisers of membrane microdomains and signalling complexes. Cell Signal 2003;15:559-564.
21. Lazo P. A., Cuevas L., Gutierrez del Arroyo A., Orue E. Ligation of CD53/OX44, a tetraspan antigen, induces homotypic adhesion mediated by specific cell-cell interactions. Cell Immunol 1997;178:132-140.
22. Bakri Y., Sarrazin S., Mayer U. P. et al. Balance of MafB and PU.l specifies alternative macrophage or dendritic cell fate. Blood 2005;105:2707-2716.
23. Wlodarski P., Zhang Q., Liu X. et al. PU.l activates transcription of SHP-1 gene in hematopoietic cells. J Biol Chem 2007;282:6316-6323.
24. Rdisanen S. R., Alatalo S. L., Ylipahkala H. et al. Macrophages overexpressing tartrate-resistant acid phosphatase show altered profile of free radical production and enhanced capacity of bacterial killing. Biochem Biophys Res Commun 2005;331:120-126.
25. Li S. L., Valente A. J., Qiang M. et al. Multiple PU.l sites cooperate in the regulation of p40 (phox) transcription during granulocytic differentiation of myeloid cells. Blood 2002;99:4578-4587.
26. Rabiet M. J., Huet E., Boulay F. The N-formyl peptide receptors and the anaphylatoxin C5a receptors: an overview. Biochimie 2007;89:1089-1106.
27. Yoshii T., Iwai M., Li Z. et al. Regression of atherosclerosis by amlodipine via anti-inflammatory and anti-oxidative stress actions. Hypertens Res 2006;29:457-466.
28. Stepien O., Zhang Y., Zhu D., Marche P. Dual mechanism of action of amlodipine in human vascular smooth muscle cells. J Hypertens 2002;20:95-102.
29. Pedersen-Lane J. H., Zurier R. B., Lawrence D. A. Analysis of the thiol status of peripheral blood leukocytes in rheumatoid arthritis patients. J Leukoc Biol 2007;81:934-941.
30. Kim T. R., Yoon J. H., Kim Y. C. et al. LPS-induced CD53expression: a protection mechanism against oxidative and radiation stress. Mol Cells 2004;17:125-131.
31. Sallusto F., Celia M., Danieli C., Lanzavecchia A. Dendritic cells use macropinocytosis and the mannose receptor to concentrate macromolecules in the major histocompatibility complex class II compartment: downregulation by cytokines and bacterial products. J Exp Med 1995;182:389-400.
32. Escola J. M., Kleijmeer M. J., Stoorvogel W. et al. Selective enrichment of tetraspan proteins on the internal vesicles of multivesicular endosomes and on exosomes secreted by human B-lymphocytes. J Biol Chem 1998;273:20121-20127.
33. Yunta M., Lazo P. A. Apoptosis protection and survival signal by the CD53 tetraspanin antigen. Oncogene 2003;22:1219-1224.
34. Yunta M. Rodriguez-Barbero A., Arivalo M. A. et al. Induction of DNA synthesis by ligation of the CD53 tetraspanin antigen in primary cultures of mesangial cells. Kidney Int 2003;63:534-542.
35. Tabas I. Consequences and therapeutic implications of macrophage apoptosis in atherosclerosis: the importance of lesion stage and phagocytic efficiency. Arterioscler Thromb Vase Biol 2005;25:2255-2264.